Fig. 2

Common drug classes implicated in drug related problems among hospitalized heart failure patients at JMC from September 30, 2020 to May 28,2021. Others: Ferrous sulphate (4.6%), Spironolactone (3.8%), digoxin (2.1%), thionamides (2.1%), antibiotics (1.7%), calcium channel blockers (1.7%), omeprazole (1.3%), cimetidine (0.8%), amiodarone (0.8%), antiTB (0.8%) and hydrochlorothiazide (0.4%). BBs beta blockers, ACEIs angiotensin converting enzyme inhibitors